Cargando…

Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution

BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Boehnke, Kevin F., Litinas, Evangelos, Worthing, Brianna, Conine, Lisa, Kruger, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831240/
https://www.ncbi.nlm.nih.gov/pubmed/33526140
http://dx.doi.org/10.1186/s42238-021-00058-0
_version_ 1783641595160035328
author Boehnke, Kevin F.
Litinas, Evangelos
Worthing, Brianna
Conine, Lisa
Kruger, Daniel J.
author_facet Boehnke, Kevin F.
Litinas, Evangelos
Worthing, Brianna
Conine, Lisa
Kruger, Daniel J.
author_sort Boehnke, Kevin F.
collection PubMed
description BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established treatment options. METHODS: We conducted an anonymous, cross-sectional online survey among patrons of a medical cannabis dispensary in Michigan (n = 275) to examine aspects of their relationship with their PCP and their perceptions of PCP knowledge related to cannabis. RESULTS: Overall, 64% of participants initiated medical cannabis use based on their own experiences vs. 24% citing advice from their PCP. Although 80% reported that their PCP knew they currently used medical cannabis, 41% reported that their PCP had not always known. Only 14% obtained their medical cannabis authorization from their PCP. Only 18% of participants rated their PCP’s knowledge about medical cannabis as very good or excellent and only 21% were very or completely confident in their PCP’s ability to integrate medical cannabis into their treatment. Although 86% had substituted cannabis for pharmaceutical medications, 69% (n = 134) of those who substituted reported some gap in their PCP’s knowledge of their substitution, and 44% (n = 86) reported that their PCP was currently unaware of their substitution. CONCLUSIONS: Patients frequently substitute cannabis for prescription drugs, often without PCP knowledge. Although most participants disclosed cannabis use to their PCP, their perceptions of PCP knowledge ranged widely and many obtained medical cannabis licensure from an outside physician. Our results highlight the need for standardized physician education around appropriate medical cannabis use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-021-00058-0.
format Online
Article
Text
id pubmed-7831240
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78312402021-01-25 Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution Boehnke, Kevin F. Litinas, Evangelos Worthing, Brianna Conine, Lisa Kruger, Daniel J. J Cannabis Res Original Research BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established treatment options. METHODS: We conducted an anonymous, cross-sectional online survey among patrons of a medical cannabis dispensary in Michigan (n = 275) to examine aspects of their relationship with their PCP and their perceptions of PCP knowledge related to cannabis. RESULTS: Overall, 64% of participants initiated medical cannabis use based on their own experiences vs. 24% citing advice from their PCP. Although 80% reported that their PCP knew they currently used medical cannabis, 41% reported that their PCP had not always known. Only 14% obtained their medical cannabis authorization from their PCP. Only 18% of participants rated their PCP’s knowledge about medical cannabis as very good or excellent and only 21% were very or completely confident in their PCP’s ability to integrate medical cannabis into their treatment. Although 86% had substituted cannabis for pharmaceutical medications, 69% (n = 134) of those who substituted reported some gap in their PCP’s knowledge of their substitution, and 44% (n = 86) reported that their PCP was currently unaware of their substitution. CONCLUSIONS: Patients frequently substitute cannabis for prescription drugs, often without PCP knowledge. Although most participants disclosed cannabis use to their PCP, their perceptions of PCP knowledge ranged widely and many obtained medical cannabis licensure from an outside physician. Our results highlight the need for standardized physician education around appropriate medical cannabis use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-021-00058-0. BioMed Central 2021-01-24 /pmc/articles/PMC7831240/ /pubmed/33526140 http://dx.doi.org/10.1186/s42238-021-00058-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Boehnke, Kevin F.
Litinas, Evangelos
Worthing, Brianna
Conine, Lisa
Kruger, Daniel J.
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title_full Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title_fullStr Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title_full_unstemmed Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title_short Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
title_sort communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831240/
https://www.ncbi.nlm.nih.gov/pubmed/33526140
http://dx.doi.org/10.1186/s42238-021-00058-0
work_keys_str_mv AT boehnkekevinf communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution
AT litinasevangelos communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution
AT worthingbrianna communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution
AT coninelisa communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution
AT krugerdanielj communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution